This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,370.35 fixed-price delivery order is for the provision of 20,000 unit vials of Thrombin-JMI, a critical medical product used in surgical procedures.
The contract has a period of performance through November 29, 2024 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
These contract awards demonstrate AmerisourceBergen's significant role as a key vendor for federal government agencies, particularly the DLA, in supplying essential pharmaceutical and medical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/26/25, 9:58 AM